News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • WISeKey H1 revenues rose 116% to $11.4M, holds ~$495M cash, expects FY revenue growth of 50–100% and Nasdaq listing WQEY.
  • Flex agreed to buy EPC Power for $4.4B and will spin off Cloud & Power Infrastructure in Q1 2027, boosting growth and margins.
  • Immix closed $125M common-stock offering, raising ~$117.1M to fund development of CAR‑T candidate NXC‑201 and general corporate needs.
  • Lumentum targets laser and optical components for AI data centers amid accelerating demand, though valuation appears rich.
  • Huntington Ingalls trades near its 52-week low despite recent $5.1B carrier RCOH award and new MUSV program win boosting near-term revenue.
  • MacKenzie Realty reported FY revenue down 9% but cut net losses, suspending preferred share repurchases while exploring strategic transactions.

Latest Articles

New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring

New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring

Trinity Biotech announced clinical trial results validating its CGM+ wearable biosensor platform’s multi-sensor technology that effectively distinguishes false low glucose readings caused by nocturnal sensor compression from true lows. The data, based on over 5,000 hours of clinical wear, demonstrates improved accuracy and reduced false alarms in c…

Ouster Shares Drop After Discounted Secondary Offering and New SEC Filings

Ouster Shares Drop After Discounted Secondary Offering and New SEC Filings

Ouster Inc. shares slumped in pre-market trading after the lidar company set an underwritten public offering of about 3.6 million shares at $55.22 each, expected to bring in roughly $200 million in gross proceeds before fees. The offering price was below the prior session close and came alongside SEC filings that indicate potential for further capi…

Forgent Power Solutions Shares Drop After Large, Discounted Equity Offering

Forgent Power Solutions Shares Drop After Large, Discounted Equity Offering

Forgent Power Solutions saw its stock slide in pre-open trading after the company and affiliated sellers priced a large, upsized offering of more than 43.6 million Class A shares at $49.00 each, a steep discount to the prior close of $55.86. The transaction, a mix of primary issuance by Forgent and secondary sales by Neos Partners-controlled entiti…

Treasure Global Secures Canadian MSB Registration to Accelerate Oxi Wallet’s Global Fintech Expansion

Treasure Global Secures Canadian MSB Registration to Accelerate Oxi Wallet’s Global Fintech Expansion

Treasure Global Inc., a Malaysia-based technology and fintech company listed on NASDAQ, has obtained a Canadian Money Services Business registration. This regulatory milestone enables the company to accelerate the global expansion of its Oxi Wallet digital financial platform, facilitating cross-border payments, remittances, and digital asset transa…

BSRTF Trade Idea: A Contrarian Long on a Potential Texas Re-rate

BSRTF Trade Idea: A Contrarian Long on a Potential Texas Re-rate

BSRTF is trading at $11.72 with neutral technicals, elevated short interest and daily short-volume spikes. This trade is a tactical, conditional long: if Texas markets normalize supply and capital flows return to REITs, small OTC names that have exposure stand to re-rate. Enter at current levels, limit risk with a tight stop and plan for a mid-term…

Energy Transfer: An MLP Engine Betting on the US Export Lift

Energy Transfer: An MLP Engine Betting on the US Export Lift

Energy Transfer (ET) trades like a high-yield utility with an embedded growth kicker from export capacity expansion. At $19.15, the partnership yields ~7% and sits on an enterprise base that generates $3.6B in free cash flow; EV/EBITDA is ~8.5x. For income investors who can stomach leverage, a measured long trade captures near-term rerating and lon…

Swarmer, Tekmara and Florida International University Explore Autonomous Drone Swarms for Coastal Restoration and Environmental Monitoring

Swarmer, Tekmara and Florida International University Explore Autonomous Drone Swarms for Coastal Restoration and Environmental Monitoring

Swarmer, Inc. (NASDAQ: SWMR), a drone autonomy software firm known for its combat drone coordination, announced a collaboration with Tekmara and Florida International University to explore using autonomous drone swarms for large-scale environmental monitoring and restoration of coastal habitats such as mangroves and oyster reefs. The partnership wi…

VisionWave Appoints Former UK Member of Parliament Ben Everitt’s Stratonex Defence Technologies as Strategic UK and European Commercialization Partner

VisionWave Appoints Former UK Member of Parliament Ben Everitt’s Stratonex Defence Technologies as Strategic UK and European Commercialization Partner

VisionWave Holdings, Inc. announced a strategic Distributor Agreement with UK-based Stratonex Defence Technologies, co-founded by former UK MP Ben Everitt, to commercialize and integrate VisionWave's advanced defense technologies across the United Kingdom, Europe, and other agreed markets. The partnership aims to enhance VisionWave’s reach in defen…

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

Revolution Medicines announced encouraging Phase 1/2 clinical trial results of its investigational oral RAS(ON) G12D-selective inhibitor zoldonrasib combined with chemotherapy and daraxonrasib for treating patients with metastatic pancreatic ductal adenocarcinoma harboring RAS G12D mutations. The data demonstrated manageable safety profiles and str…

Hudbay Receives Regulatory Approval to Further Increase Mill Throughput at its Constancia Mine in Peru

Hudbay Receives Regulatory Approval to Further Increase Mill Throughput at its Constancia Mine in Peru

Hudbay Minerals Inc. announced that it has obtained approval from Peru's SENACE to amend its environmental permit, allowing an increase in the Constancia mine's mill throughput capacity from 31 million to 34 million tonnes of ore annually. This amendment marks the fifth permit change and supports operational optimization, extended mine life, and im…

ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events

ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events

ZenaTech, Inc., a Nasdaq-listed AI drone technology company, announced its participation in a series of investor and defense industry events across the U.S. and globally. The company aims to showcase its growth in Drone as a Service (DaaS), highlight its subsidiary ZenaDrone's advanced AI-powered drone defense solutions, and build relationships wit…

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Medical's wholly owned subsidiary Cortigent, Inc. is set to merge with ClearOne, Inc., a Nasdaq-listed company, resulting in a new entity named Cortigent Holdings, Inc. trading under the ticker CRGT. The transaction includes a financing round between $10M and $15M to fund development of Cortigent's neurostimulation brain-computer interface t…

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations

YD Bio Limited announced that its U.S. clinical laboratory affiliate, EG BioMed US Inc., has obtained clinical lab licenses in Rhode Island and Pennsylvania, expanding its U.S. lab footprint to 46 states plus DC and Guam. This expansion enhances patient access to early cancer detection tests based on DNA methylation and supports the company's trans…